Research from the Nemeth Lab has been published in numerous influential journals in the fields of hematology, endocrinology and immunotherapy.

Figure from a scientific research study

FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia

  • Journal: Leukemia, January 2024
  • Authors: Sung PJ, et al.
  • Citation: Leukemia. 2024 Jan 5. doi: 10.1038/s41375-023-02131-4.

PubMedFull text

Figure from a scientific research study

Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator

  • Journal: Journal for Immunotherapy of Cancer, September 2022
  • Authors: Oliver L, et al.
  • Citation: J Immunother Cancer. 2022 Sep;10(9):e004710

PubMedFull text

Cover of a scientific journal

Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression

  • Journal: Journal of Clinical Investigaition, December 2022
  • Authors: Colligan SH, Amitrano AM, Zollo RA, Peresie J, Kramer ED, Morreale B, Barbi J, Singh PK, Yu H, Wang J, Opyrchal M, Sykes DB, Nemeth MJ, Abrams SI.
  • Citation: J Clin Invest. 2022 Dec 1;132(23):e158661. doi: 10.1172/JCI158661.

PubMedFull textNews release

View more on PubMed

Connect with the Nemeth Lab

Email: Michael.Nemeth@RoswellPark.org
Phone: 716-845-1775

Department of Immunology
Roswell Park Comprehensive Cancer Center
Elm and Carlton Streets
Buffalo, NY 14263